Overview
- Through Disposición 16/2026, ANMAT prohibited neutral gels and base creams sold under QUIFAM, VEPO, ECOTIDY, ACTIVA LAB and NAMECO for lacking sanitary registration and producer identification, with sales detected on Mercado Libre.
- Disposición 18/2026 halted all lots of the injectable antibiotic DANFERANE I.V. (Trimethoprim 80 mg + Sulfamethoxazole 400 mg, Certificate No. 43.621) from P.L. Rivero y Cía. S.A. after records showed no authorization for an alternate manufacturer.
- An inspection tied to the DANFERANE case found deficiencies classified as “critical,” leading ANMAT to order preventive inhibition of the company’s production and to open a sanitary summary.
- A separate disposition targeted Rosario-based LADECE S.A., prohibiting and ordering the withdrawal of multiple pharmacopoeia products following a Santa Fe Health Ministry inspection that uncovered production and authorization irregularities.
- ANMAT instructed immobilization and market withdrawals and notified provincial health authorities to enforce the prohibitions and prevent further circulation nationwide.